Purpose
to generate highly potent monoclonal antibodies against the Plasmodium falciparum’s circumsporozoite (CSP) protein with the goal of preventing malaria in vulnerable populations
Grantee
Division
Global Health
Date
SEPTEMBER 2022
Region served
AFRICA
Committed amount
$1,387,197
Grant topic
Malaria
Duration (months)
56
Grantee location
Boston, Massachusetts, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.